Logo image of OSTK

OVERSTOCK.COM INC (OSTK) Stock Fundamental Analysis

NASDAQ:OSTK - Nasdaq - US6903701018 - Common Stock - Currency: USD

16.78  +0.87 (+5.47%)

After market: 17 +0.22 (+1.31%)

Fundamental Rating

2

Overall OSTK gets a fundamental rating of 2 out of 10. We evaluated OSTK against 120 industry peers in the Specialty Retail industry. OSTK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OSTK does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

OSTK had negative earnings in the past year.
In the past year OSTK has reported a negative cash flow from operations.
In multiple years OSTK reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: OSTK reported negative operating cash flow in multiple years.
OSTK Yearly Net Income VS EBIT VS OCF VS FCFOSTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 100M -100M 200M -200M 300M

1.2 Ratios

With a Return On Assets value of -16.97%, OSTK is not doing good in the industry: 81.68% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -24.00%, OSTK is doing worse than 64.12% of the companies in the same industry.
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROIC N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A
OSTK Yearly ROA, ROE, ROICOSTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150

1.3 Margins

OSTK has a Gross Margin of 22.84%. This is in the lower half of the industry: OSTK underperforms 75.57% of its industry peers.
OSTK's Gross Margin has improved in the last couple of years.
OSTK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%
OSTK Yearly Profit, Operating, Gross MarginsOSTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20

More info and screens

5

2. Health

2.1 Basic Checks

OSTK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OSTK has been increased compared to 1 year ago.
OSTK has a worse debt/assets ratio than last year.
OSTK Yearly Shares OutstandingOSTK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
OSTK Yearly Total Debt VS Total AssetsOSTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

OSTK has an Altman-Z score of 3.78. This indicates that OSTK is financially healthy and has little risk of bankruptcy at the moment.
OSTK has a Altman-Z score of 3.78. This is amongst the best in the industry. OSTK outperforms 80.15% of its industry peers.
OSTK has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
OSTK's Debt to Equity ratio of 0.06 is fine compared to the rest of the industry. OSTK outperforms 74.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.78
ROIC/WACCN/A
WACC9.19%
OSTK Yearly LT Debt VS Equity VS FCFOSTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.97 indicates that OSTK should not have too much problems paying its short term obligations.
OSTK has a better Current ratio (1.97) than 77.86% of its industry peers.
A Quick Ratio of 1.94 indicates that OSTK should not have too much problems paying its short term obligations.
The Quick ratio of OSTK (1.94) is better than 87.79% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.94
OSTK Yearly Current Assets VS Current LiabilitesOSTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for OSTK have decreased strongly by -102.27% in the last year.
OSTK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -42.51%.
OSTK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.03% yearly.
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Sales Q2Q%-60.32%

3.2 Future

OSTK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.97% yearly.
OSTK is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.93% yearly.
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OSTK Yearly Revenue VS EstimatesOSTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
OSTK Yearly EPS VS EstimatesOSTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4 -6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OSTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OSTK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OSTK Price Earnings VS Forward Price EarningsOSTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400 -500

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OSTK indicates a slightly more expensive valuation: OSTK is more expensive than 65.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 48.99
OSTK Per share dataOSTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

OSTK's earnings are expected to decrease with -22.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OSTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OVERSTOCK.COM INC

NASDAQ:OSTK (11/3/2023, 8:14:30 PM)

After market: 17 +0.22 (+1.31%)

16.78

+0.87 (+5.47%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)10-26 2023-10-26/bmo
Earnings (Next)02-20 2024-02-20/amc
Inst Owners63.52%
Inst Owner Change-88.49%
Ins Owners4.25%
Ins Owner Change0%
Market Cap760.13M
Analysts71.76
Price Target22.95 (36.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.31%
Min EPS beat(2)36.41%
Max EPS beat(2)78.21%
EPS beat(4)3
Avg EPS beat(4)-38.5%
Min EPS beat(4)-296.08%
Max EPS beat(4)78.21%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.78%
Min Revenue beat(2)1.03%
Max Revenue beat(2)4.52%
Revenue beat(4)2
Avg Revenue beat(4)-2.64%
Min Revenue beat(4)-11.53%
Max Revenue beat(4)4.52%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-41.05%
PT rev (3m)-47.27%
EPS NQ rev (1m)-10.42%
EPS NQ rev (3m)-154.86%
EPS NY rev (1m)5.79%
EPS NY rev (3m)-76.5%
Revenue NQ rev (1m)-0.26%
Revenue NQ rev (3m)-4.01%
Revenue NY rev (1m)0.18%
Revenue NY rev (3m)-2.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF N/A
P/OCF N/A
P/B 1.33
P/tB 1.4
EV/EBITDA 48.99
EPS(TTM)-0.03
EYN/A
EPS(NY)-1.15
Fwd EYN/A
FCF(TTM)-1.3
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS36.83
BVpS12.65
TBVpS11.95
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.97%
ROE -24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.84%
FCFM N/A
ROA(3y)11.65%
ROA(5y)-7.67%
ROE(3y)18.42%
ROE(5y)-41.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)11.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.63%
GM growth 5Y3.32%
F-Score3
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA 3.7
Cap/Depr 230.01%
Cap/Sales 2.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.94
Altman-Z 3.78
F-Score3
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)74.77%
Cap/Depr(5y)83.05%
Cap/Sales(3y)0.68%
Cap/Sales(5y)1.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-102.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-110.53%
EPS Next Y-352.74%
EPS Next 2Y-106.12%
EPS Next 3Y-22.55%
EPS Next 5Y12.97%
Revenue 1Y (TTM)-42.51%
Revenue growth 3Y10.37%
Revenue growth 5Y2.03%
Sales Q2Q%-60.32%
Revenue Next Year-19.05%
Revenue Next 2Y-6.61%
Revenue Next 3Y-2.73%
Revenue Next 5Y-0.93%
EBIT growth 1Y-111.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-264.4%
EBIT Next 3Y3.2%
EBIT Next 5Y17.06%
FCF growth 1Y-151.85%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.08%
OCF growth 3YN/A
OCF growth 5YN/A